BIG INTERVIEW
Bridging the brain drain – how the UK can become a new hub for US scientists
The UK can build on the strong foundations it has already laid to attract the best talent and drive the next generation of scientific discovery, says Rafael Carazo Salas, CEO and founder of CellVoyant.
This year we have witnessed a...
VR is cool – but can it attract young people into medicines manufacturing?
Ivan Wall is Professor of Regenerative Medicine at the University of Birmingham and co-director of Resilience - the UK’s Medicines Manufacturing Skills Centre of Excellence.
Handling charge
Advanced medicines manufacturing is suffering from an acute skills gap, and not enough young...
Uncovering new cures from cancer survivors
Researchers at Oxford techbio Etcembly hope to find new targets for cancer therapies by analysing the immune cells of cancer survivors, as principal scientist Mathew Jones explains.
Despite all the advances in medicine over the past few decades, curing cancer...
Mission Genomics to launch the UK economy
UK-wide genetic testing will boost health, save lives, and create a new pathway for economic innovation, says Dr Stuart J. Grice, co-founder and CSO at FitnessGenes.
The United Kingdom is at the forefront of genomics research. Initiatives like the UK...
Collaboration, Clustering and Converting
Partnerships between small biotechs and Big Pharma could unlock faster drug development for rare diseases, says Dan Williams, PhD, CEO of SynaptixBio.
In an increasingly interconnected and competitive world, collaboration has become an essential tool for organisations of all sizes....
Llamas: leading the pack in new cancer therapy
Llama antibodies - known as VHHs or nanobodies - could be a gamechanger for precision medicine. Marion Cubitt, Director of Discovery at Isogenica, explains how an accidental discovery opened a fresh pathway for immunotherapy.
Tell us about Isogenica’s work
Isogenica are...
Breaking boundaries in bio manufacturing
Eric Fua, Conference Producer, IMAPAC UK, investigates the challenges and opportunities facing the biomanufacturing industry.
Last year, the global biomanufacturing market surged to an astounding US$19.02 billion, signifying the sector’s potential to revolutionise global health.1
Biopharmaceutical manufacturing (or biomanufacturing) is today...
The changing face of cancer care
Breast cancer patients could be spared unnecessary chemotherapy thanks to a new gene test. Karen Southern chats to surgical oncologist, Prof Simon Holt, about how genomic breakthroughs like Oncotype DX are transforming UK cancer care.
As of 2019, the UK...
Advanced testing is vital to prevent bird flu pandemic
Is the UK prepared for a potential bird flu epidemic among humans? The answer is no, says influenza virologist and lecturer, Dr Nicole Robb.
The odds of a bird - or avian - flu outbreak in people are low, with...
Defining the future of experiment design
Synthace is a biotech start-up accelerating biological discovery and optimisation through computer-aided biology. CEO Guy Levy-Yurista tells Bioscience Today why this is the decade when life sciences’ biggest challenges will be solved - in a matter of days.
If you...
Next-generation biologics: today’s reality
Shark molecules provide the basis of unique new therapeutics which could transform the treatment of inflammatory diseases and cancer. Karen Southern talks to Dr Caroline Barelle, CEO and founder of Elasmogen, the small biopharmaceutical company behind this potentially huge...
T cells: their increasing significance in infectious disease diagnosis and research
Peter Wrighton-Smith, CEO of Oxford Immunotec, talks to Bioscience Today about growing understanding of the importance of T cells in protecting us from disease, as well as their critical role in measuring immune responses to infection.
The coronavirus (COVID-19) pandemic,...
Biotech pioneer tackles the biology of ageing
Living to a ripe old age is one thing. Enjoying a healthy, ripe old age is the challenge. Biotech veteran Dr Eric Leire aims to slow ageing by design, as he explains to Karen Southern.
The quest for immortality (or...
Biosample provenance: what researchers need to know
Why is the current system for sourcing samples broken? And what does this mean for researchers who use biosamples? Robert Hewitt, MB BS, PhD, of Biosample Hub, investigates.
The journey for every biospecimen used for medical research is different. It...
SAGES TEACH THE ART OF ADAPTING TO CLIMATE CHANGE
While the conversation about climate change has been dominated by mitigation, what is equally crucial is the need to adapt to the unavoidable changes already on their way. “We have absolutely no choice but to learn to adapt to...
PROFESSOR HONOURED FOR HER WORK ON PANDEMIC CONTROL
A Women in Science event held earlier this year demonstrated that women are certainly coming into their own in the fields of science, technology, engineering and maths.
In this, the final feature in a three-part series about women making waves,...
THE ROAD LESS TRAVELLED
A Women in Science event that took place in Newcastle upon Tyne’s Biosphere business incubator earlier this year certainly demonstrated that women are finally coming into their own in the fields of science, technology, engineering and maths.
In this, the...
TABBY CAT OR TIGER?
Medics need to be fleet of foot when it comes to determining whether they are dealing with something tame or wild, but the traditional route to identifying bacteria takes time. Now a team of Harvard researchers is coming to...
Life Science success
Whilst the recent past has been one of huge uncertainty with regards to the political and economic landscape across the globe, the past year saw major success in Life Sciences & Healthcare across the Eastern region.
Tony Jones, CEO, One Nucleus
Record...
Nobel prize winner talks to us
Dr Frances Arnold, the American chemist and engineer who won the 2018 Nobel Prize in Chemistry and the 2016 Millennium Technology Prize for her work in pioneering directed evolution reveals more about her work.Â
Dr Frances Arnold, the American chemist...
Making clinical trials right for older people
In this issue, we speak to Miles Witham, Professor of Trials for Older People at Newcastle University and consultant geriatrician, about why he’s bringing about a sea change in how clinical trials involving older people are designed and carried...
Simplicity is all
In this issue of BioScience Today, Ellen Rossiter speaks to Professor Kawal Rhode about his work in the realm of biomedical engineering, his inspiration, motivation and why simplicity is all.
“Way back in school, we were taught science in a...
Why life science incubators are crucial
In this issue of BioScience Today, we speak to Dr Glenn Crocker MBE, Chief Executive Officer of BioCity – the largest life science incubator business in the UK.
The lowdown on life science incubators
“A life science incubator can mean different...
Meeting contemporary medical challenges
In this issue of BioScience Today, we speak to Professor Phil Blower, Chair in Imaging Chemistry at King’s College London about why a multidisciplinary approach is crucial to meeting the medical challenges of today.
“I work in a branch of...
Raising awareness of PSP and CBD
Ellen Rossiter speaks to Andrew Symons, Chief Executive of PSP Association, about the work of the association and his hopes for the future.
Imagine striving daily to raise awareness of, and to find a cure for, a condition which few...
